As the U.S. stock market navigates a landscape marked by cautious optimism following a benign inflation reading, investors are closely monitoring potential volatility amid ongoing economic developments and policy decisions. In this context, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business and may offer robust earnings potential despite broader market uncertainties.
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.7% |
Super Micro Computer (NasdaqGS:SMCI) | 14.4% | 24.3% |
Duolingo (NasdaqGS:DUOL) | 14.7% | 34.6% |
On Holding (NYSE:ONON) | 19.1% | 29.4% |
Clene (NasdaqCM:CLNN) | 21.6% | 59.2% |
EHang Holdings (NasdaqGM:EH) | 32.8% | 81.5% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 13.4% | 66.3% |
BBB Foods (NYSE:TBBB) | 22.9% | 41.5% |
Credit Acceptance (NasdaqGS:CACC) | 14.0% | 49% |
ARS Pharmaceuticals (NasdaqGM:SPRY) | 19.7% | 70.7% |
Click here to see the full list of 199 stocks from our Fast Growing US Companies With High Insider Ownership screener.
Let's uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: ChromaDex Corporation is a bioscience company that develops healthy aging products, with a market cap of $436.34 million.
Operations: The company generates revenue through three main segments: Ingredients ($16.95 million), Consumer Products ($71.72 million), and Analytical Reference Standards and Services ($3.00 million).
Insider Ownership: 30.5%
Earnings Growth Forecast: 81.8% p.a.
ChromaDex has demonstrated significant growth potential, with revenue forecasted to grow at 18.1% annually, surpassing the US market average. Recent developments include a nationwide rollout of Niagen IV, enhancing its product reach and contributing to its projected 15% revenue increase for 2024. The company has shown improved profitability with US$1.88 million in net income for Q3 2024 compared to a loss last year. Insider activity shows more buying than selling recently, indicating confidence in future performance.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Root, Inc. operates in the United States offering insurance products and services, with a market cap of approximately $1.08 billion.
Operations: The company generates revenue of $1.04 billion from offering insurance products to customers in the United States.
Insider Ownership: 20.4%
Earnings Growth Forecast: 119.5% p.a.
Root has expanded its insurance services to Minnesota, now covering over 77% of the U.S. population. Recent earnings show significant improvement with Q3 revenue at US$305.7 million and net income of US$21.7 million, reversing previous losses. Despite a volatile share price and insider selling, Root's refinancing deal with BlackRock reduces interest expenses by about 50%, enhancing financial flexibility for growth initiatives. However, shareholder dilution occurred in the past year amidst expected profitability within three years.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genius Sports Limited develops and sells technology-driven products and services for the sports, sports betting, and sports media industries, with a market cap of $1.81 billion.
Operations: The company's revenue primarily comes from its Data Processing segment, which generated $462.54 million.
Insider Ownership: 11.2%
Earnings Growth Forecast: 71.6% p.a.
Genius Sports, with substantial insider ownership, is positioned for growth as it forecasts a 15% annual revenue increase, outpacing the US market. Recent Q3 results show sales of US$120.2 million and a net income turnaround to US$12.51 million from a prior loss. The company launched FANHub, leveraging its extensive sports data network. Leadership changes include appointing Robbie Bach to the board and Mark Kropf as CTO to drive technological advancement in their AI platform GeniusIQ.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include NasdaqCM:CDXC NasdaqGS:ROOT and NYSE:GENI.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.